FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103151 [Registered on: 06/02/2026] Trial Registered Prospectively
Last Modified On: 05/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   Can Strength Training Boost Mental Well-Being and Heart Health? A Study Using Salivary Markers 
Scientific Title of Study   Analysing the Impact of Resistance Training on Psychological Health, Quality of Life, and Atherosclerosis Using Salivary Biomarkers among Early Middle Aged Individuals 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  kilani Kusuma 
Designation  PhD scholar  
Affiliation  Meenakshi Academy Of Higher Education And Research 
Address  Meenakshi Academy of Higher Education and Research 12 Vembuliamman Koil Street Annaji Nagar KK Nagar West KK Nagar, Chennai, Tamil Nadu 600087

Chennai
TAMIL NADU
600087
India 
Phone  09866395084  
Fax    
Email  kilani_res@maher.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.P.V.Hari Hara Subramanyan 
Designation  Associate professor  
Affiliation  Meenakshi Academy Of Higher Education And Research 
Address  Meenakshi Of Physiotherapy, Meenakshi Academy Of Higher Education and Research, KK NAGAR 600078

Chennai
TAMIL NADU
600002
India 
Phone  9444840543  
Fax    
Email  hari@maherfpt.ac.in   
 
Details of Contact Person
Public Query
 
Name  kilani Kusuma 
Designation  PhD scholar  
Affiliation  Meenakshi Academy Of Higher Education And Research 
Address  Faculty Of Physiotherapy, Meenakshi Academy Of Higher Education And Research KK NAGAR 600078

Chennai
TAMIL NADU
600002
India 
Phone  09866395084  
Fax    
Email  kilani_res@maher.com  
 
Source of Monetary or Material Support  
MEENAKSHI ACADEMY OF HIGHER EDUCATION and RESEARCH Vembuliamman Koil Street, West KK Nagar, Chennai, Tamil Nadu, India 600 078 
 
Primary Sponsor  
Name  KILANI KUSUMA 
Address  12, Vembuliamman Koil St, Annaji Nagar, KK Nagar West, K. K. Nagar, Chennai, Tamil Nadu 600087 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
kilani Kusuma  Meenakshi Academy of Higher Education and Research and its Constituent Colleges  Department of Physiotherapy, Faculty of Allied Health Sciences, Room No. 1
Chennai
TAMIL NADU 
09866395084

kilani_res@maher.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Meenakshi Institutional Human Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  apparently healthy participants 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  HEART health education program with no exercise intervention for 12 weeks(3months)   12 Weeks Weekly Once 3 Months Key Points Covered Week 1 Understanding Mental Wellbeing Introduction to mental health self awareness emotional check ins and stigma reduction Week 2 Stress Management Techniques Recognizing stress triggers deep breathing journaling and guided imagery Week 3 Sleep Hygiene Importance of sleep sleep cycle basics tips for quality sleep and creating a sleep friendly environment Week 4 Healthy Eating for the Mind Impact of nutrition on mood brain foods mindful eating and hydration Week 5 Social Health and Relationships Importance of social connections communication skills empathy and setting boundaries Week 6 Time and Routine Management Structuring your day using planners reducing procrastination and balancing work life Week 7 Coping with Anxiety What is anxiety identifying symptoms grounding techniques and calming activities Week 8 Building Self Esteem Understanding self worth positive affirmations and body image positivity Week 9 Avoiding Burnout Signs of burnout energy conservation work rest balance and saying no when needed Week 10 Digital Wellness Screen time awareness impact of social media digital detox ideas and sleep tech balance Week 11 General Health Awareness Preventive health checks importance of hydration oral and skin hygiene and reducing substance use Week 12 Recap and Goal Setting Review of previous topics individual goal discussion health journaling and motivation techniques 
Intervention  resistance training FOR 12 WEEKS, TWICE WEEKLY (3 months)  1.chest press 2.push up 3.shoulder press 4.shoulder raise.5.Seated row 6.triceps extension 7.biceps curl 8.squat 9.abdominal crunch 10.back extension. 
 
Inclusion Criteria  
Age From  34.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  Individuals aged between 34 and 45 years old with less interpersonal communication.
Individuals who are having long working hours according to the self-framed proforma.
Individuals with irregular sleep patterns and poor sleep quality as per self-framed proforma.

Appeared healthy and had no impediments such as motor limitations with upper and lower extremities.
Subjects had no history of cardiopulmonary diseases and chronic illness.
 
 
ExclusionCriteria 
Details  Individuals who suffer from oral pathology.
Individuals who suffer from periodontitis.
Individuals who have adenoiditis.
Individuals suffering with tonsillitis.
Individuals who have tongue thrust.
Individuals who have snoring.
Individuals who suffer from temporal mandibular problems.
Individuals who have recurrent apthous stomatitis.
Individuals having disorders of the V, VII, and IX cranial nerves.
Currently taking psychotropic or anti-inflammatory drugs.
Those with a BMI of 30 or higher.
Individuals who have high blood pressure.
Individuals who suffer from autoimmune or chronic inflammatory diseases.
Pregnancy.
It had been six months since they last engaged in isokinetic resistance training
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Changes in IL-6 and CRP levels from baseline (1st week) to post-intervention at 12th week.  Pre-test at baseline (1st week) and post-test at the end of 12 weeks.
 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in stress levels & quality of life from baseline (1st week) to the end of the intervention (12th week).
 
Baseline (1st week) & 12 weeks.
 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   16/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Completed 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Trial Progress Summary:
Participant recruitment for the study has been successfully completed as per the approved sample size from 5 different working organizations. apparently healthy individuals were recruited.  All enrolled participants have undergone the planned intervention, and the study is currently in the final phase of intervention completion. No major protocol deviations or adverse events have been reported during the study period. Data collection through salivary biomarkers, psychological health scales, quality of life questionnaires, and atherosclerosis-related measures has been completed for the majority of participants, with final follow-up assessments underway.

The study is progressing as per the approved timeline, and overall trial completion is expected shortly upon completing the remaining assessments and beginning data analysis. All procedures are being conducted according to the CTRI-approved protocol and ethical guidelines.

Category Details
Total Approved Sample Size 100 participants
Total Recruited Participants 100 participants
Experimental Group 50 participants
Control Group 50 participants
Intervention Status – Experimental Group Completed 21 out of 24 sessions
Intervention Status – Control Group Completed 12-week health education program
Recruitment Status Completed
Retention Rate 100% (No dropouts reported)
Major Issues Faced No major issues reported. Minor challenge: difficulty gathering participants at one place.
Expected Date of Overall Study Completion December 25th, 2025
Adherence to Protocol Within acceptable limits; no significant deviations.
 
Close